Perceptive Advisors LLC
- SEC CIK
- 0001224962
- 最新申報
- 2026/8/14
2022 年第 3 季持倉
持倉截至 2022/9/30，2022/11/14 申報。只含多頭部位，變化是跟 2022 年第 2 季比股數。
- 持股檔數
- 115
- 較 2022 年第 2 季 +6
- 總值
- $34.4 億
- 較 2022 年第 2 季 +$2.58 億 (+8.1%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| FOLDAmicus Therapeutics, Inc. | COM | 27,372,917 | $2.86 億 | 8.3% | +477,385+1.8% | 加碼 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 2,784,796 | $1.94 億 | 5.7% | −82,067−2.9% | 減碼 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 6,511,727 | $1.84 億 | 5.3% | +1,425,000+28.0% | 加碼 | 歷史 |
| GBTGlobal Blood Therapeutics, Inc. | COM | 2,322,247 | $1.58 億 | 4.6% | −692,807−23.0% | 減碼 | 歷史 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 5,472,033 | $1.54 億 | 4.5% | +1,931,625+54.6% | 加碼 | 歷史 |
| LIANYLianBio | SPONSORED ADS | 57,558,451 | $1.15 億 | 3.3% | +998,240+1.8% | 加碼 | 歷史 |
| CINCCinCor Pharma, Inc. | COM | 3,306,649 | $1.09 億 | 3.2% | +987,532+42.6% | 加碼 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 10,247,073 | $1.08 億 | 3.1% | +4,712,904+85.2% | 加碼 | – |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 5,321,032 | $1.05 億 | 3.0% | 00.0% | 不變 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 3,470,563 | $9,902 萬 | 2.9% | −396,883−10.3% | 減碼 | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 10,248,624 | $9,818 萬 | 2.9% | −1,577,675−13.3% | 減碼 | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 2,383,478 | $8,824 萬 | 2.6% | +2,262,128+1,864.1% | 加碼 | 歷史 |
| RXDXPrometheus Biosciences, Inc. | COM | 1,468,512 | $8,666 萬 | 2.5% | −213,730−12.7% | 減碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 2,122,535 | $7,662 萬 | 2.2% | 00.0% | 不變 | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 11,350,085 | $6,061 萬 | 1.8% | +1,446,206+14.6% | 加碼 | 歷史 |
| MGTXMeiraGTx Holdings plc | COM | 6,963,277 | $5,856 萬 | 1.7% | 00.0% | 不變 | 歷史 |
| INBXInhibrx Biosciences, Inc. | COM | 2,887,860 | $5,184 萬 | 1.5% | +973,268+50.8% | 加碼 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 5,047,264 | $5,158 萬 | 1.5% | +2,132,118+73.1% | 加碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 3,207,441 | $4,786 萬 | 1.4% | +118,469+3.8% | 加碼 | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 2,465,405 | $4,628 萬 | 1.3% | +1,323,415+115.9% | 加碼 | 歷史 |
| Travere Therapeutics, Inc.89422GAA5 | NOTE 2.250% 3/0 | – | $4,598 萬 | 1.3% | – | – | – |
| LYRALyra Therapeutics, Inc. | COM | 9,146,730 | $4,583 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| ALBOAlbireo Pharma, Inc. | COM | 2,360,139 | $4,569 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| VERUVeru Inc. | COM | 3,893,000 | $4,485 萬 | 1.3% | +393,000+11.2% | 加碼 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 1,943,097 | $4,347 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| SGENSeagen Inc. | COM | 316,544 | $4,331 萬 | 1.3% | +92,544+41.3% | 加碼 | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 1,713,134 | $4,122 萬 | 1.2% | −200,657−10.5% | 減碼 | 歷史 |
| VBIVVBI Vaccines Inc/BC | COM NEW | 52,335,002 | $3,716 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| TMCITreace Medical Concepts, Inc. | COM | 1,601,979 | $3,536 萬 | 1.0% | +660,787+70.2% | 加碼 | 歷史 |
| NUVLNuvalent, Inc. | COM | 1,655,007 | $3,217 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 578,253 | $3,158 萬 | 0.9% | +172,494+42.5% | 加碼 | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 336,481 | $2,852 萬 | 0.8% | +156,481+86.9% | 加碼 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 253,000 | $2,797 萬 | 0.8% | +253,000 | 新進 | 歷史 |
| EWEdwards Lifesciences Corp | Stock | 330,000 | $2,727 萬 | 0.8% | +330,000 | 新進 | 歷史 |
| ZYMEZymeworks Inc. | COM | 4,400,099 | $2,706 萬 | 0.8% | +267,565+6.5% | 加碼 | 歷史 |
| ADMAAdma Biologics, Inc. | COM | 10,933,387 | $2,657 萬 | 0.8% | −587,715−5.1% | 減碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 1,220,575 | $2,503 萬 | 0.7% | +248,743+25.6% | 加碼 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 366,400 | $2,503 萬 | 0.7% | +45,100+14.0% | 加碼 | 歷史 |
| IMTXImmatics N.V. | SHS | 2,500,000 | $2,500 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| CMAXCareMax, Inc. | COM CL A | 3,394,939 | $2,407 萬 | 0.7% | +394,939+13.2% | 加碼 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 1,296,416 | $2,219 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| RVNCRevance Therapeutics, Inc. | COM | 808,671 | $2,183 萬 | 0.6% | +236,157+41.2% | 加碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 331,023 | $2,151 萬 | 0.6% | −36,478−9.9% | 減碼 | 歷史 |
| NAUTNautilus Biotechnology, Inc. | COM | 9,111,151 | $1,932 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| CTKBCytek Biosciences, Inc. | COM | 1,289,534 | $1,898 萬 | 0.6% | +1,289,534 | 新進 | 歷史 |
| OMOutset Medical, Inc. | COM | 1,168,630 | $1,862 萬 | 0.5% | +169,903+17.0% | 加碼 | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 1,034,169 | $1,855 萬 | 0.5% | −1,053,787−50.5% | 減碼 | 歷史 |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 411,804 | $1,824 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 666,477 | $1,744 萬 | 0.5% | +666,477 | 新進 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 1,697,033 | $1,687 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| AORTArtivion, Inc. | COM | 1,204,229 | $1,667 萬 | 0.5% | +274,524+29.5% | 加碼 | 歷史 |
| CHRSCoherus Oncology, Inc. | COM | 1,667,123 | $1,602 萬 | 0.5% | −1,978,348−54.3% | 減碼 | 歷史 |
| VRCAVerrica Pharmaceuticals Inc. | COM | 5,038,983 | $1,471 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 430,000 | $1,464 萬 | 0.4% | +430,000 | 新進 | 歷史 |
| CNCEConcert Pharmaceuticals, Inc. | COM | 2,150,641 | $1,441 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| LONALeonaBio, Inc. | COM | 4,797,278 | $1,425 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| PRTAProthena Corp Public Ltd Co | SHS | 230,000 | $1,395 萬 | 0.4% | +230,000 | 新進 | 歷史 |
| DICEDICE Therapeutics, Inc. | COM | 687,424 | $1,394 萬 | 0.4% | −364,480−34.6% | 減碼 | 歷史 |
| HLVXHilleVax, Inc. | COM | 764,907 | $1,307 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| Rain Oncology Inc.75082Q105 | COM | 2,483,619 | $1,212 萬 | 0.4% | 00.0% | 不變 | – |
| ATXSAstria Therapeutics, Inc. | COM | 1,281,197 | $1,158 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| AXGNAxogen, Inc. | COM | 949,626 | $1,132 萬 | 0.3% | +949,626 | 新進 | 歷史 |
| PRCTPROCEPT BioRobotics Corp | COM | 263,720 | $1,093 萬 | 0.3% | −485,980−64.8% | 減碼 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 100,050 | $1,063 萬 | 0.3% | −297,838−74.9% | 減碼 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 363,197 | $1,028 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| ChemoCentryx, Inc.16383L106 | COM | 192,680 | $995.4 萬 | 0.3% | −249,000−56.4% | 減碼 | – |
| LABPLandos Biopharma, Inc. | COM | 14,869,915 | $966.5 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| LRMRLarimar Therapeutics, Inc. | COM | 2,860,000 | $915.2 萬 | 0.3% | +2,860,000 | 新進 | 歷史 |
| OMICSingular Genomics Systems, Inc. | COM | 3,536,274 | $884.1 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 500,000 | $798.0 萬 | 0.2% | −666,883−57.2% | 減碼 | 歷史 |
| KRONKronos Bio, Inc. | COM | 2,156,151 | $722.3 萬 | 0.2% | −264,991−10.9% | 減碼 | 歷史 |
| ISOIsoPlexis Corp | COM | 4,095,498 | $704.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| NVRONevro Corp | COM | 150,000 | $699.0 萬 | 0.2% | +150,000 | 新進 | 歷史 |
| CCCCC4 Therapeutics, Inc. | COM STK | 766,231 | $672.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| CYPHCypherpunk Technologies Inc. | COM | 7,472,148 | $657.5 萬 | 0.2% | −479,300−6.0% | 減碼 | 歷史 |
| SLDBSolid Biosciences Inc. | COM | 13,412,552 | $625.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 310,500 | $612.3 萬 | 0.2% | +310,500 | 新進 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 341,239 | $537.1 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| NTRANatera, Inc. | COM | 120,000 | $525.8 萬 | 0.2% | +120,000 | 新進 | 歷史 |
| NARIInari Medical, Inc. | Stock | 70,000 | $508.5 萬 | 0.1% | +70,000 | 新進 | 歷史 |
| NVNOenVVeno Medical Corp | COMMON STOCK | 781,615 | $490.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| WGSGeneDx Holdings Corp. | COMMON STOCK | 5,000,000 | $439.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| SLGCSomaLogic, Inc. | CLASS A COM | 1,500,000 | $435.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| TYRATyra Biosciences, Inc. | COM | 494,403 | $434.6 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CTICCti Biopharma Corp | COM | 735,165 | $427.9 萬 | 0.1% | +735,165 | 新進 | 歷史 |
| ATNXAthenex, Inc. | COM | 15,532,467 | $417.8 萬 | 0.1% | +2,000,000+14.8% | 加碼 | 歷史 |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 400,000 | $401.2 萬 | 0.1% | −108,532−21.3% | 減碼 | 歷史 |
| PNTPOINT Biopharma Global Inc. | COM | 500,000 | $386.5 萬 | 0.1% | −573,995−53.4% | 減碼 | 歷史 |
| HCATHealth Catalyst, Inc. | COM | 389,962 | $378.3 萬 | 0.1% | −75,200−16.2% | 減碼 | 歷史 |
| NBTXNanobiotix S.A. | SPONSORED ADS | 1,059,800 | $375.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Coherus Biosciences Inc19249HAB9 | NOTE 1.500% 4/1 | – | $359.2 萬 | 0.1% | – | – | – |
| YMABY-mAbs Therapeutics, Inc. | COM | 212,018 | $305.7 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 1,528,812 | $301.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ABSIAbsci Corp | COM | 894,346 | $279.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| PSTXPoseida Therapeutics, Inc. | COM | 750,000 | $264.8 萬 | 0.1% | +750,000 | 新進 | 歷史 |
| CLOVClover Health Investments, Corp. | COM CL A | 1,500,000 | $255.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| RETAReata Pharmaceuticals Inc | CL A | 100,000 | $251.3 萬 | 0.1% | +100,000 | 新進 | 歷史 |
| QTNTQuotient Ltd | SHS | 16,200,818 | $243.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| SNCEScience 37 Holdings, Inc. | COM | 1,500,000 | $241.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| FULCFulcrum Therapeutics, Inc. | COM | 294,118 | $237.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
選擇權（1 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| TCDATricida, Inc. | COM | $524.0 萬 | – |
2022 年第 2 季之後清倉（9 檔）
2022 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2022 年第 2 季股數 | 2022 年第 2 季市值 | 2022 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| LLYEli Lilly & Co | Stock | 100,000 | $3,242 萬 | 1.0% | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 172,991 | $2,523 萬 | 0.8% | 歷史 |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 556,047 | $995.3 萬 | 0.3% | 歷史 |
| PRVAPrivia Health Group, Inc. | COM | 273,423 | $796.2 萬 | 0.3% | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 1,769,701 | $573.3 萬 | 0.2% | 歷史 |
| MGNXMacrogenics Inc | COM | 1,227,202 | $362.0 萬 | 0.1% | 歷史 |
| FUSNFusion Pharmaceuticals Inc. | COM | 1,052,445 | $262.1 萬 | 0.1% | 歷史 |
| RACEFerrari N.V. | COM | 6,200 | $113.8 萬 | <0.1% | 歷史 |
| ZYZymergen Inc. | COM | 883,332 | $108.6 萬 | <0.1% | 歷史 |